Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWeight loss clinic injections are prescription-only medicines — currently Mounjaro (tirzepatide) and Wegovy (semaglutide) — given once a week by subcutaneous injection. They work by acting on appetite-regulating hormones in the gut, reducing hunger and slowing digestion. Both are licensed in the UK for adults with a qualifying BMI, and both require a clinical assessment before a prescriber can issue a prescription. Learn more about how these injections work before deciding whether a consultation makes sense for you. These are not over-the-counter medicines; a prescriber reviews your health history and decides whether treatment is appropriate, regardless of where you access it, a physical clinic or a regulated online pharmacy.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is whether you have to travel to a physical clinic to get these injections. The short answer is no, not in the UK, not for this type of medicine. What matters legally and clinically is that a qualified, GPhC-registered prescriber reviews your health information, not where that review takes place. If you want to understand what a legitimate service looks like before deciding, our guide to weight loss injections clinics explains what to look for and how the process typically works. Some people prefer a face-to-face appointment; others find a regulated online service faster and more private.
Either way, the process is similar: you answer questions about your health, weight, medical history and any medicines you take. The prescriber checks whether you meet the licensed eligibility criteria, considers any contraindications, and makes a clinical decision. At a physical clinic you might sit in a waiting room first. Through a regulated online pharmacy like ours, your answers are reviewed the same day by a named prescriber, a real clinician reads them, not software. If you'd like to see who oversees clinical decisions at nume, our clinical team page explains that.
What neither route can do is promise approval in advance. Eligibility is a clinical judgement, and any service that guarantees access before assessing you is not operating to the standard you'd want for a prescription medicine.
The licensed criteria are set by the medicines' regulators, not by individual clinics. For Mounjaro, UK licensing covers adults with a BMI of 30 or above, or a BMI from 27 upwards if at least one weight-related health condition is present, for example, high blood pressure, high cholesterol, prediabetes, type 2 diabetes, or obstructive sleep apnoea. Wegovy carries similar thresholds. The NHS eligibility picture is more restrictive: NICE's published guidance layers on additional conditions and, for now, limits NHS access to phased cohorts.
Private providers, including regulated online pharmacies, can work to the broader licensed criteria, which means some people who don't currently qualify for NHS treatment may still be suitable for private prescription. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance, your prescriber will factor this into their assessment.
BMI alone never seals the decision. A prescriber also considers your medication list, any history of pancreatitis, thyroid conditions, or certain gastrointestinal disorders, and whether you're pregnant, breastfeeding, or planning to conceive. If any of those apply, these medicines are not recommended. The same applies to anyone under 18, neither Mounjaro nor Wegovy is licensed for that age group.
If you're trying to find a weight loss injections clinic near you, it's worth understanding what a legitimate service looks like before you search, as the range of options varies considerably by location and provider.
Both tirzepatide and semaglutide share a broadly similar side-effect profile, dominated by gastrointestinal symptoms. Nausea is the most commonly reported one; others include loose stools, constipation, indigestion, and occasionally vomiting. These effects tend to be most noticeable in the first few weeks of treatment or after a dose increase, and many people find they settle as the body adjusts.
This is part of why the dosing schedule for both medicines starts low (2.5mg for tirzepatide, 0.25mg for semaglutide) and increases gradually under prescriber oversight. The NHS's patient-level guide to tirzepatide on NHS.uk covers the side-effect list clearly and is worth reading before you start.
A few symptoms deserve prompt medical attention. Severe, persistent stomach pain that spreads to the back (with or without vomiting) could signal pancreatitis, which the MHRA flagged in a Drug Safety Update in January 2026 as an infrequent but serious risk with GLP-1 medicines. Symptoms of gallbladder problems, signs of a serious allergic reaction, or significant dehydration from prolonged vomiting or diarrhoea should also prompt you to get help quickly rather than wait for your next check-in. You can report any suspected side effect through the MHRA Yellow Card scheme.
Women taking oral contraceptives should know that tirzepatide may reduce pill absorption during the first four weeks of treatment and for four weeks after each dose increase. Your prescriber will advise on adding a barrier method during those windows.
It depends on your situation, and there's no single right answer. NHS access to Mounjaro and Wegovy is expanding but remains tightly phased. As of mid-2026, Mounjaro on the NHS requires a BMI of 40 or above alongside multiple qualifying conditions, criteria that many people don't meet, even with genuine weight-related health concerns. Wegovy through NHS specialist services typically involves long waiting lists. If you'd like a fuller breakdown, getting weight loss injections on the NHS sets out the current pathway honestly.
Choosing a private clinic for weight loss injections means no referral, no waiting list, and a consultation that's reviewed the same day, though it also costs money: private prescriptions for these medicines run into the hundreds of pounds per month, and the right question to ask any provider is what the headline price actually includes. Some clinics charge separately for the consultation, the prescription, delivery, and any follow-up support. A price that looks lower upfront can end up costing more across a course of treatment.
For a clearer sense of what influences private pricing, the weight management treatment overview covers this alongside the clinical context. If you'd like to explore whether you're suitable for treatment with us, you can check your eligibility and start a free consultation, our prescribers review your answers the same day, and there's no obligation to proceed.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.